Plasminogen activator inhibitor-1 regulates infiltration of macrophages into melanoma via phosphorylation of FAK-Tyr925

Biochemical and Biophysical Research Communications

Volumn 450, Issue 4, 2014, Pages 1696-1701

  Thapa, Bikash ^a   Koo, Bon Hun ^a   Kim, Yeon Hyang ^a   Kwon, Hyung Joo ^b   Kim, Doo Sik ^a  

^a Yonsei University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

FAK; Invasion; LRP1; Macrophage; Melanoma; PAI 1

Indexed keywords

FAK; INVASION; LRP1; MACROPHAGE; MELANOMA; PAI-1;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, LDL; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

EID: 84906100079     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.070     Document Type: Article

References (28)

1. S.K. Mitra, D.A. Hanson, and D.D. Schlaepfer Focal adhesion kinase: in command and control of cell motility Nat. Rev. Mol. Cell. Biol. l 6 2005 56 68
2. J.T. Parsons Focal adhesion kinase: the first ten years J. Cell Sci. 116 2003 1409 1416
3. T.B. Deramaudt, D. Dujardin, A. Hamadi, F. Noulet, K. Kolli, J. De Mey, K. Takeda, and P. Ronde FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion Mol. Biol. Cell 22 2011 964 975
4. M.K. Durand, J.S. Bodker, A. Christensen, D.M. Dupont, M. Hansen, J.K. Jensen, S. Kjelgaard, L. Mathiasen, K.E. Pedersen, S. Skeldal, T. Wind, and P.A. Andreasen Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis Thromb. Haemost. 91 2004 438 449
5. F. Schroeck, N. Arroyo de Prada, S. Sperl, M. Schmitt, and M. Viktor Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn Biol. Chem. 383 2002 1143 1149
6. A. Zhou, J.A. Huntington, N.S. Pannu, R.W. Carrell, and R.J. Read How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration Nat. Struct. Biol. 10 2003 541 544
7. R.P. Czekay, K. Aertgeerts, S.A. Curriden, and D.J. Loskutoff Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins J. Cell Biol. 160 2003 781 791
8. A.P. Lillis, I. Mikhailenko, and D.K. Strickland Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability J. Thromb. Haemost. 3 2005 1884 1893
9. S. Dedieu, B. Langlois, J. Devy, B. Sid, P. Henriet, H. Sartelet, G. Bellon, H. Emonard, and L. Martiny LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities Mol. Cell. Biol. 28 2008 2980 2995
10. N. Garg, N. Goyal, T.L. Strawn, J. Wu, K.M. Mann, D.A. Lawrence, and W.P. Fay Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices J. Thromb. Haemost. 8 2010 1847 1854
11. M.J. Wijnberg, P.H. Quax, N.M. Nieuwenbroek, and J.H. Verheijen The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein Thromb. Haemost. 78 1997 880 886
12. P. Chen, Y. Huang, R. Bong, Y. Ding, N. Song, X. Wang, X. Song, and Y. Luo Tumor-Associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner Clin. Cancer Res. 17 2011 7230 7239
13. K. Weiskopf, A.M. Ring, C.C. Ho, J.P. Volkmer, A.M. Levin, A.K. Volkmer, E. Ozkan, N.B. Fernhoff, M. van de Rijn, I.L. Weissman, and K.C. Garcia Engineered SIRPalpha variants as immunotherapeutic adjuvants to anticancer antibodies Science 341 2013 88 91
14. M. De Palma, and C.E. Lewis Macrophage regulation of tumor responses to anticancer therapies Cancer Cell 23 2013 277 286
15. B. Thapa, Y.H. Kim, H.J. Kwon, and D.S. Kim Novel regulatory mechanism and functional implication of plasminogen activator inhibitor-1 (PAI-1) expression in CpG-ODN-stimulated macrophages Mol. Immunol. 49 2012 572 581
16. B. Thapa, Y.H. Kim, H.J. Kwon, and D.S. Kim The LRP1-independent mechanism of PAI-1-induced migration in CpG-ODN activated macrophages Int. J. Biochem. Cell Biol. 49 2014 17 25
17. T. Senoo, N. Hattori, T. Tanimoto, M. Furonaka, N. Ishikawa, K. Fujitaka, Y. Haruta, H. Murai, A. Yokoyama, and N. Kohno Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis Thorax 65 2010 334 340
18. O. Masson, C. Chavey, C. Dray, A. Meulle, D. Daviaud, D. Quilliot, C. Muller, P. Valet, and E. Liaudet-Coopman LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue PLoS One 4 2009 e7422
19. M. Tanaka, S. Kuriyama, and N. Aiba Nm23-H1 regulates contact inhibition of locomotion, which is affected by ephrin-B1 J. Cell Sci. 125 2012 4343 4353
20. M.B. Berkenpas, D.A. Lawrence, and D. Ginsburg Molecular evolution of plasminogen activator inhibitor-1 functional stability EMBO J. 14 1995 2969 2977
21. G. Liu, M.A. Shuman, and R.L. Cohen Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells Int. J. Cancer 60 1995 501 506
22. H. Kobayashi, N. Moniwa, J. Gotoh, M. Sugimura, and T. Terao Role of activated protein C in facilitating basement membrane invasion by tumor cells Cancer Res. 54 1994 261 267
23. G.A. Soff, J. Sanderowitz, S. Gately, E. Verrusio, I. Weiss, S. Brem, and H.C. Kwaan Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-Associated angiogenesis, and metastasis to lung and liver in an athymic mouse model J. Clin. Invest. 96 1995 2593 2600
24. B. Stabuc, J. Markovic, I. Bartenjev, I. Vrhovec, U. Medved, and B. Kocijancic Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma Oncol. Rep. 10 2003 635 639
25. D.T. Eitzman, J.C. Krauss, T. Shen, and J. Cui Ginsburg, lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma Blood 87 1996 4718 4722
26. S.C. Robinson, K.A. Scott, J.L. Wilson, R.G. Thompson, A.E. Proudfoot, and F.R. Balkwill A chemokine receptor antagonist inhibits experimental breast tumor growth Cancer Res. 63 2003 8360 8365
27. N.B. Hao, M.H. Lu, Y.H. Fan, Y.L. Cao, Z.R. Zhang, and S.M. Yang Macrophages in tumor microenvironments and the progression of tumors Clin. Dev. Immunol. 2012 2012 948098
28. C. Guiducci, A.P. Vicari, S. Sangaletti, G. Trinchieri, and M.P. Colombo Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection Cancer Res. 65 2005 3437 3446